I'm creating another account just for you! Learn How I Plan to Turn

$5,000 into $25,000

Phase 1: $5,000 - $25,000 (estimated time needed: 3 months)

Most new traders think you need a huge account to make money in the market, but that is completely false. I'm going to show you exactly how it's done, starting with just $5,000. Trade over my shoulder!

Phase 2: $25,000 - $200,000 (estimated time needed: 3 months)

I started this 2 months ago and have taken $25000 into over $100,000. I will keep growing this account and helping every step of the way. The $5,000 account will be another individual account. No matter the stage you're in, I've got you covered!

Phase 3: $200,000 - $1,000,000 (estimated time needed: 1 year)

This is where I'll show you how to use $200,000 to make $1,000,000+ yearly. And since I normally trade with about $200,000 in my account, you'll learn EVERY account hacking strategy I have, something I call 'trading buckets' to make $1,000,000+ each year

Trading stocks is inherently risky. There is no guarantee you will make money or replicate Kyle's performance nor that Kyle will be able to replicate past results.

How to Join Me

  1. Only for BiotechBreakouts.com Nucleus subscribers
  2. Phase I starts January 2nd, 2018.
  3. Phase II has begun. I've turned $25,000 into over $100,000 so far. Everything is being recorded.
  4. If you have a small account, you need to be in here before the new year starts. I'm taking $5,000 to $25,000 and want you to do it with me!

| save 70% with promocode: xmas70

SAVE 70% NOW! Deal ends in:


Millionaire Reveals Top Trade Idea Each Week

RagingBull.com CEO, Jeff Bishop, shares his top pick for the week each Monday, straight to your inbox.

“My strategy aims to help you pull one winner out of the market each week, regardless of market conditions!” – Jeff Bishop

When you think about trading biotech or pharmaceutical stocks… the first thing that pops into most people’s mind is, Johnson & Johnson, Merck & Co. or Novartis

Companies like Melinta Therapeutics and Chiasma are foreign to most casual traders.  

However, if action is what you’re after — and what I mean by that is the potential to return massive profits in a short period of time—then you’ll have to get comfortable trading the smaller and lesser-known pharmaceutical stocks.

Through trial and error, I developed my FDA Insider Alerts system that lets me know EXACTLY when and what biotech stock to buy.

No, I’m not getting some insider information… I’m doing my due diligence—identifying chart patterns and catalyst events that signal when a stock could run up.

I’ve been on rinse and repeat mode for some time now…

That trade above took less than 2 weeks to develop…

The thing is, in order for you to take advantage of opportunities like this, you need to uncover the catalyst events that biotech traders, like myself, are focused on…

However, you have no chance at success if you aren’t up on the key terms. I’m referring to the language you need to understand to profit off FDA catalyst events.

Once you hear this term… it’s time to make a move

One of the most important terms in the cycle of every biotech and pharmaceutical companies’ life is PDUFA.

PDUFA is just short for the Prescription Drug User Fee Act.

Basically, this is one term I look for when I’m filtering for biotech trades… and it’s the first step in the 3-step system. If you don’t know how my strategy works, check out my last post here.

Let’s get some background information about the Prescription Drug User Fee Act (PDUFA).

Under PDUFA, the U.S. Food & Drug Administration (FDA) has about 10 months to review a new drug application.

It’s a law that allows the FDA to collect fees from biotech and pharmaceutical companies seeking drug approval — allowing them to partially finance the process of approval.

I know, it sounds as if you need to go back to school to understand this whole process, just to trade biotech stocks.

However, all you really need to do is find out when the PDUFA date is. You see, it’s a specific date when FDA experts meet and approve or reject a treatment.

That simplifies things right?

But that’s not the best part…

… biotech stocks tend to release their PDUFA dates to give traders and investors a heads up.

That means we know exactly which stocks to trade… and when to place the trades.

When it comes to PDUFA dates… you’ll sometimes hear me refer to them as FDA approval dates — and once my clients hear me mention FDA approval, they know it’s time to keep the stock on the radar.

But the thing is… there are so many biotechs out there, how do you know which ones to trade?

It’s simple…

I look through an extensive calendar and place them on my watchlist, with the exact price range I’m looking to get into.

For example, my clients get to see the “uncensored” version of this… they know the stock, the exact catalyst, a detailed trade plan, as well as the catalyst date.

They also receive my entry… and of course my exit alerts…

It’s the fourth quarter… and that means there are a lot of potential catalyst runup opportunities.

If you haven’t done so, now’s the time to diversify your profit buckets and leverage the power of FDA Insider Trades to stack up in this volatile market.

You May Also Like:

Exclusive System Tracks Wall St. Insiders

“Dollar Ace Simply Exposes Information That Wall Street Wants To Keep Quiet” Said Kyle Dennis
“One member, Wesley M., has already reported 360%+ gains in just a few short days. Don’t miss this!”
(Reserve Access Now)

“What Recession?!” Jason Bond nets $55,060 in realized profit in One Day

After going 6 for 6 on profitable trades recently, we caught up with Jason to ask how he did it.
Check out Jason’s exclusive interview revealing this tightly guarded strategy. (Watch Now)

RagingBull.com Co-Founder, Jeff Bishop, Launches High Conviction Trade Service

“We listen to our clients and we give them EXACTLY what they want, so we designed a service to deliver 1 trade, 1 time a week, with a 100%+ PROFIT TARGET, directly to your inbox every Monday before the market opens.” (Read More)